Anebulo Pharmaceuticals(ANEB) - 2025 Q1 - Quarterly Results

Financial Results - Anebulo Pharmaceuticals reported its financial results for Q3 2024 on November 13, 2024[2] - The financial results announcement includes a business update alongside the earnings report[2] - The report does not specify detailed financial metrics or performance indicators in the provided content[3] Company Classification - The company is classified as an emerging growth company under the Securities Act[2] Stock Information - Anebulo Pharmaceuticals' common stock is traded on The Nasdaq Stock Market under the symbol ANEB[1] Press Release - The press release detailing the financial results is included as Exhibit 99.1[4]